SMR vs NNE: which stock is the better buy?
NuScale Power Corporation and Nano Nuclear Energy Inc., graded by the same fixed-weight model from live fundamentals — composite score, 12-month forecast, valuation, growth and margins, side by side. As of July 6, 2026.
On today’s numbers, Nano Nuclear Energy Inc. grades higher — 58/100 vs 43/100. Tap either card for the full factor breakdown.
Metric by metric
| Metric | SMR | NNE |
|---|---|---|
| TradersQuant Score | 43/100 | 58/100 ✓ |
| Price | $9.76 | $20.03 |
| 12-mo base forecast | $4.88 | $18.37 |
| Implied upside | -50.0% | -8.3% ✓ |
| Bull / bear range | $9.09 / $1.47 | $28.79 / $11.10 |
| P/E | -4.0 | -29.0 ✓ |
| Forward P/E | — | — |
| Revenue growth (YoY) | -15.0% | +0.0% ✓ |
| Gross margin | 22.4% ✓ | 0.0% |
| Market cap | $2.9B | $833M |
| Sector | Utilities | Industrials |
✓ marks the stronger reading per metric (lower is better for P/E). Figures refresh continuously; research, not financial advice.
Want the full verdict on SMR and NNE?
The AI bull/base/bear thesis, smart-money positioning, options signals and insider activity on both — every systematic call graded in public against the S&P 500.
$0 today · cancel before day 7 and you won’t be charged
SMR vs NNE — FAQ (2026)
Is SMR or NNE the better buy right now?
On the live TradersQuant composite score, Nano Nuclear Energy Inc. (NNE) currently grades higher at 58/100 versus 43/100 for SMR. The score weighs valuation, growth, earnings quality, momentum, the macro regime, sentiment and balance-sheet risk — open each stock's page for the full breakdown. Research, not financial advice.
Which has more 12-month upside, SMR or NNE?
TradersQuant's 12-month base-case forecast currently implies -50.0% for SMR and -8.3% for NNE. Both forecasts are three-scenario models (bull/base/bear) refreshed continuously and graded on our public track record.
How is this SMR vs NNE comparison calculated?
Both stocks are scored by the same fixed-weight model — 20% valuation, 20% growth, 15% earnings quality, 15% momentum, 10% macro regime fit, 10% analyst sentiment, 10% balance-sheet risk — from live fundamentals and prices. No hand-picking: the same arithmetic runs on every stock we cover, and our systematic calls are graded in public against the S&P 500.